RESUMO
Maternal Zika virus (ZIKV) infection during pregnancy has been associated with severe intrauterine growth restriction (IUGR), placental damage, metabolism disturbances, and newborn neurological abnormalities. Here, we investigated the impact of maternal ZIKV infection on placental nutrient transporters and nutrient-sensitive pathways. Immunocompetent (C57BL/6) mice were injected with Low (103 PFU-ZIKVPE243) or High (5 × 107 PFU-ZIKVPE243) ZIKV titers at gestational day (GD) 12.5, and tissue was collected at GD18.5 (term). Fetal-placental growth was impaired in male fetuses, which exhibited higher placental expression of the ZIKV infective marker, eukaryotic translation initiation factor 2 (eIF2α), but lower levels of phospho-eIF2α. There were no differences in fetal-placental growth in female fetuses, which exhibited no significant alterations in placental ZIKV infective markers. Furthermore, ZIKV promoted increased expression of glucose transporter type 1 (Slc2a1/Glut1) and decreased levels of glucose-6-phosphate in female placentae, with no differences in amino acid transport potential. In contrast, ZIKV did not impact glucose transporters in male placentae but downregulated sodium-coupled neutral amino acid 2 (Snat2) transporter expression. We also observed sex-dependent differences in the hexosamine biosynthesis pathway (HBP) and O-GlcNAcylation in ZIKV-infected pregnancies, showing that ZIKV can disturb placental nutrient sensing. Our findings highlight molecular alterations in the placenta caused by maternal ZIKV infection, shedding light on nutrient transport, sensing, and availability. Our results also suggest that female and male placentae employ distinct coping mechanisms in response to ZIKV-induced metabolic changes, providing insights into therapeutic approaches for congenital Zika syndrome.
Assuntos
Desenvolvimento Fetal , Camundongos Endogâmicos C57BL , Placenta , Transdução de Sinais , Infecção por Zika virus , Zika virus , Animais , Feminino , Infecção por Zika virus/metabolismo , Infecção por Zika virus/virologia , Gravidez , Camundongos , Placenta/metabolismo , Placenta/virologia , Masculino , Desenvolvimento Fetal/fisiologia , Complicações Infecciosas na Gravidez/virologia , Complicações Infecciosas na Gravidez/metabolismo , Nutrientes/metabolismo , Transportador de Glucose Tipo 1/metabolismoRESUMO
Influenza A virus (IAV) infection during pregnancy can increase the risk for neurodevelopmental disorders in the offspring, however, the underlying neurobiological mechanisms are largely unknown. To recapitulate viral infection, preclinical studies have traditionally focused on using synthetic viral mimetics, rather than live IAV, to examine consequences of maternal immune activation (MIA)-dependent processes on offspring. In contrast, few studies have used live IAV to assess effects on global gene expression, and none to date have addressed whether moderate IAV, mimicking seasonal influenza disease, alters normal gene expression trajectories in different brain regions across different stages of development. Herein, we show that moderate IAV infection during pregnancy, which causes mild maternal disease and no overt foetal complications in utero, induces lasting effects on the offspring into adulthood. We observed behavioural changes in adult offspring, including disrupted prepulse inhibition, dopaminergic hyper-responsiveness, and spatial recognition memory deficits. Gene profiling in the offspring brain from neonate to adolescence revealed persistent alterations to normal gene expression trajectories in the prefronal cortex, hippocampus, hypothalamus and cerebellum. Alterations were found in genes involved in inflammation and neurogenesis, which were predominately dysregulated in neonatal and early adolescent offspring. Notably, late adolescent offspring born from IAV infected mice displayed altered microglial morphology in the hippocampus. In conclusion, we show that moderate IAV during pregnancy perturbs neurodevelopmental trajectories in the offspring, including alterations in the neuroinflammatory gene expression profile and microglial number and morphology in the hippocampus, resulting in behavioural changes in adult offspring. Such early perturbations may underlie the vulnerability in human offspring for the later development of neurodevelopmental disorders, including schizophrenia. Our work highlights the importance of using live IAV in developing novel preclinical models that better recapitulate the real-world impact of inflammatory insults during pregnancy on offspring neurodevelopmental trajectories and disease susceptibility later in life.
Assuntos
Encéfalo , Vírus da Influenza A , Infecções por Orthomyxoviridae , Efeitos Tardios da Exposição Pré-Natal , Animais , Feminino , Gravidez , Camundongos , Encéfalo/metabolismo , Efeitos Tardios da Exposição Pré-Natal/metabolismo , Infecções por Orthomyxoviridae/metabolismo , Complicações Infecciosas na Gravidez/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Hipocampo/metabolismo , Transtornos do Neurodesenvolvimento/metabolismo , Transtornos do Neurodesenvolvimento/genética , Expressão Gênica , Modelos Animais de DoençasRESUMO
INTRODUCTION: Several factors influence transmission of 2019-nCoV from mother to fetus during pregnancy, thus the dynamics of vertical transmission is unclear. The role of cellular protective factors, namely a 90 KDa glycoprotein, Early pregnancy-associated protein (Epap-1), expressed by placental endothelial cells in women during early pregnancy would provide an insight into role of placental factors in virus transmission. Since viral spike protein binding to the ACE2 receptors of the host cells promotes virus invasion in placental tissue, an analysis of effects of Epap-1 on the Spike-ACE2 protein binding was studied. METHODS: Epap-1 was isolated from MTP placental tissue. Molecular interaction of Epap-1 and variants of the spike was analyzed in silco. The interaction of Epap-1 with Spike and RBD were analyzed using ELISA and immunofluorescence studies. RESULTS: The results in silico showed an interaction of Epap-1 with S-protein at RBD region involving K417, Y449, Y453, Y456, Y473, Q474, F486, Q498, N501 residues of spike with Y61, F287, I302, N303, N305, S334, N465, G467, N468 residues of Epap-1 leading to interference of S-protein and ACE2 interaction [1]. Further, the interaction is conserved among the variants. The studies in vitro confirm that Epap-1 affects S protein-ACE2 and RBD- ACE2 binding, thus suggesting that during early pregnancy, SARS CoV-2 infection may be protected by Epap-1 protein present in placental tissue. The results were further confirmed by pseudovirus expressing Spike and RBD in an infection assay. DISCUSSION: Epap-1 interferes with Spike and RBD interaction with ACE2, suggesting a possible mechanism of the antiviral environment during pregnancy.
Assuntos
Enzima de Conversão de Angiotensina 2 , COVID-19 , Transmissão Vertical de Doenças Infecciosas , Placenta , SARS-CoV-2 , Glicoproteína da Espícula de Coronavírus , Feminino , Humanos , Gravidez , Enzima de Conversão de Angiotensina 2/metabolismo , Betacoronavirus/metabolismo , Infecções por Coronavirus/transmissão , Infecções por Coronavirus/metabolismo , Infecções por Coronavirus/virologia , COVID-19/transmissão , COVID-19/metabolismo , Pandemias , Peptidil Dipeptidase A/metabolismo , Placenta/metabolismo , Placenta/virologia , Pneumonia Viral/metabolismo , Pneumonia Viral/transmissão , Pneumonia Viral/virologia , Complicações Infecciosas na Gravidez/metabolismo , Complicações Infecciosas na Gravidez/virologia , Proteínas da Gravidez/metabolismo , Ligação Proteica , SARS-CoV-2/metabolismo , Glicoproteína da Espícula de Coronavírus/metabolismoRESUMO
PURPOSE: In view of conflicting reports on the ability of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to infect placental tissue, this study aimed to further evaluate the impact of inflammation and placental damage from symptomatic third-trimester maternal COVID-19 infection. MATERIALS AND METHODS: This case-control study included 32 placenta samples each from symptomatic COVID-19 pregnancy and normal non-COVID-19 pregnancy. The villous placental area's inflammatory expression [angiotensin converting enzyme-2 (ACE-2), transmembrane protease serine-2 (TMPRSS2), interferon-γ (IFN-γ), interleukin-6 (IL-6), and SARS-CoV-2 spike protein] and apoptotic rate were examined using immunohistochemistry and Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay. Comparison and correlation analysis were used based on COVID-19 infection, placental SARS-CoV-2 spike protein evidence, and maternal severity status. RESULTS: Higher expressions of TMPRSS2, IFN-γ, and trophoblast apoptotic rate were observed in the COVID-19 group (p<0.001), whereas ACE-2 and IL-6 expressions were not significantly different from the control group (p>0.05). Additionally, SARS-CoV-2 spike protein was detected in 8 (25%) placental samples of COVID-19 pregnancy. COVID-19 subgroup analysis revealed increased IFN-γ, trophoblast, and stromal apoptosis (p<0.01). Moreover, the results of the current study revealed no correlation between maternal COVID-19 severity and placental inflammation as well as the apoptotic process. CONCLUSION: The presence of SARS-CoV-2 spike protein as well as altered inflammatory and apoptotic processes may indicate the presence of placental disturbance in third-trimester maternal COVID-19 infection. The lack of correlation between placental disruption and maternal severity status suggests the need for more research to understand the infection process and any potential long-term impacts on all offsprings born to COVID-19-infected pregnant women.
Assuntos
COVID-19 , Complicações Infecciosas na Gravidez , Glicoproteína da Espícula de Coronavírus , Feminino , Gravidez , Humanos , Placenta/metabolismo , SARS-CoV-2 , Terceiro Trimestre da Gravidez , Estudos de Casos e Controles , Interleucina-6/metabolismo , Complicações Infecciosas na Gravidez/metabolismo , Inflamação/metabolismo , ApoptoseRESUMO
This paper presents a case of osteonecrosis of the jaw related to zoledronic acid (5 mg) administered once yearly to treat osteoporosis. A 79-year-old woman who has been treated for osteoporosis for 5 years with 5 applications of zoledronic acid was referred for evaluation. The patient had been submitted to dental implant placement and there was no osseointegration. On clinical examination, suppuration and exposed bone on the alveolar ridge were observed. Radiographic examination revealed an osteolytic area and bone sequestration. Both clinical and radiological features were suggestive of osteonecrosis. The treatment consisted of surgery to remove the affected bone completely. The patient is asymptomatic at 9 months after surgery. Dentists and oral surgeons should be alert to the possibility of osteonecrosis related to the use of once-yearly injections of zoledronic acid for the treatment of postmenopausal osteoporosis.
O presente estudo teve como objetivo apresentar um caso de osteonecrose dos maxilares associada ao uso de ácido zoledrônico (5 mg) administrado uma vez ao ano para tratar a osteoporose. Uma mulher de 79 anos de idade estava em tratamento de osteoporose por 5 anos com 5 aplicações do ácido zoledrônico foi encaminhada para nossa avaliação. A paciente tinha sido submetida à colocação de implante dental e não houve osseointegração. Ao exame clínico, supuração e osso exposto no rebordo alveolar foram observados. Os exames radiográficos revelaram uma área osteolítica e sequestro ósseo. Ambos os aspectos clínicos e radiográficos eram sugestivos de osteonecrose. O tratamento consistiu de cirurgia para remover todo o osso afetado. A paciente está assintomática há 9 meses (desde a cirurgia). Cirurgiões-dentistas e cirurgiões orais devem estar atentos para a possibilidade de osteonecrose relacionada ao uso de injeções anuais de ácido zoledrônico para tratamento da osteoporose pós-menopausa.
Assuntos
Feminino , Humanos , Gravidez , Encéfalo/patologia , Diferenciação Celular , Encefalite/patologia , Complicações Infecciosas na Gravidez/patologia , Encéfalo/metabolismo , Encefalite/metabolismo , Feto/metabolismo , Feto/patologia , Proteína Glial Fibrilar Ácida/metabolismo , Neuroglia/metabolismo , Neurônios/metabolismo , Complicações Infecciosas na Gravidez/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismoRESUMO
OBJETIVO: Aquilatar a prevalência da vaginose bacteriana e comparar a acurácia dos testes do pH e do KOH com o gradiente de Nugent, método padrão-ouro, no diagnóstico da vaginose bacteriana (VB) em gestantes assintomáticas e sintomáticas de baixo risco. MÉTODOS: Foi realizado um estudo de corte transversal em 321 grávidas, com idade gestacional entre 14ª e 26ª semanas, 218 assintomáticas e 103 com queixa de secreção vaginal sugestiva de vaginose bacteriana. Todas as gestantes foram avaliadas pelos critérios de Nugent e submetidas à pHmetria vaginal e ao teste do KOH a 10%. O coeficiente de Kappa foi utilizado para avaliar os métodos quanto à concordância diagnóstica. RESULTADO: A maioria das gestantes era adolescente (média etária 21,0±5,6 anos), nulípara e parda. A prevalência da vaginose bacteriana foi de 33,3% pelo método de pH e KOH e de 35,5% pelo Nugent. Entre as grávidas assintomáticas, foi observada ótima concordância dos métodos, com 72,5% delas apresentando resultados negativos para ambos os métodos, o que resultou em um elevado coeficiente de Kappa (k=0,82). No grupo de gestantes sintomáticas, houve 49,5% de positividade para ambos os métodos diagnósticos, demonstrando ótima concordância (k=0,74). CONCLUSÃO: A prevalência da vaginose bacteriana foi elevada tanto pelo método de pH e KOH quanto pelo Nugent. O método do pH e KOH é tão capaz em diagnosticar a vaginose bacteriana quanto os critérios de Nugent.
PURPOSE: To assess the prevalence of bacterial vaginosis and to compare the accuracy of testing pH and KOH with the Nugent gradient, the gold standard for the diagnosis of bacterial vaginosis (BV) in asymptomatic and symptomatic pregnant women at low risk. METHODS: We conducted a cross-sectional study on 321 pregnant women with gestational age between 14 and 26 weeks, 218 of them asymptomatic and 103 with vaginal complaints suggestive of bacterial vaginosis. All women were assessed by the criteria of Nugent and subjected to the measurement of vaginal pH and to the 10% KOH test. The Kappa coefficient was used to evaluate the methods in terms of diagnostic agreement. RESULTS: Most patients were adolescents (mean age 21.0±5.6 years), nulliparous and mulattos. The prevalence of bacterial vaginosis was 33.3% as estimated by the pH and KOH method and 35.5% by the Nugent method. Excellent agreement of the methods was found among asymptomatic pregnant women, with 72.5% of them showing negative results to both tests, which resulted in a high Kappa coefficient (k=0.82). The group of symptomatic women showed 49.5% positivity to both diagnostic methods, with excellent agreement (k=0.74). CONCLUSION: The prevalence of bacterial vaginosis determined by both the pH and KOH method and the Nugent score was high. The pH and KOH method can diagnose bacterial vaginosis as accurately as the Nugent criterion.
Assuntos
Adolescente , Criança , Feminino , Humanos , Gravidez , Adulto Jovem , Complicações Infecciosas na Gravidez/diagnóstico , Vaginose Bacteriana/diagnóstico , Estudos Transversais , Concentração de Íons de Hidrogênio , Hidróxidos , Compostos de Potássio , Prevalência , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/metabolismo , Reprodutibilidade dos Testes , Vaginose Bacteriana/epidemiologia , Vaginose Bacteriana/metabolismoRESUMO
As seis formas de hepatites virais constituem uma relativamente comum e bastante séria infecção que poderá atingir as gestantes,condicionando danos a elas e seriamente comprometendo todo o evoluir da gravidez.Os quadros de hepatite aguda na gestação necessitam internação hospitalar se existir algum sinal de encefalopatia aguda, coagulopatia ou grave debilidade devido a má-nutrição.Nessas eventualidades pode haver necessidade de reposição de sangue e fatores da coagulação sanguínea,tais como plasma fresco criocipitados.Aproximadamente 10% a 20% das mulheres que são soropositivas para o HBsAg podem transmitir aos seus fetos o HBV e,entre as pacientes que são positivas para o HBsAg e HBeAg,a possibilidade de transmissão atinge os 90%.A vacinação de recém-nascidos de mães soropositivas é indicada.Há risco de transmição de hepatite intraparto.
Assuntos
Humanos , Feminino , Gravidez , Complicações Infecciosas na Gravidez/imunologia , Complicações Infecciosas na Gravidez/metabolismo , Hepatite Viral Humana/diagnóstico , Hepatite Viral Humana/patologia , Hepatite Viral Humana/transmissão , GestantesRESUMO
O parto pré-termo é uma das grandes intercorrências obstétricas, sendo a maior causa de morbidade e mortalidade perinatal. Dentre os diferentes fatores envolvidos no seu desencadeamento, a infecção intra-amniótica parece representar um papel central. As infecções desencadeiam resposta inflamatória nos tecidos materno e fetal, mediada pela produção de citocinas inflamatórias. As citocinas induzem a liberação de prostaglandinas, aumentando a contratilidade uterina, favorecendo a rotura das membranas fetais, a modificação e dilatação da cérvice e, finalmente, o parto pré-termo. A síntese de citocinas depende de controle genético. Diversos polimorfismos relacionados a genes humanos codificadores de citocinas são reconhecidos e associados a fenótipos de alta, média e baixa produção desses fatores. Assim sendo, a relação entre determinados genótipos e a ocorrência e/ou características de diferentes patologias tem sido investigada. Este tipo de abordagem pode contribuir para o conhecimento da patogenia, permitindo o reconhecimento de parâmetros preditivos e a definição de novas estratégias terapêuticas.
Preterm birth is a major obstetric incident and one of the main causes of perinatal mortality and morbidity. Among the different factors involved in its unleashing, intra-amniotic infection seems to play a central role. The infections unleash inflammatory response in both maternal and fetal tissues, mediated by the production of inflammatory cytokines. They also lead to liberation of prostaglandin, which increases myometrial contractility, favoring the rupture of fetal membrane, alteration and dilation of the cervix and, finally, preterm birth. The production of cytokines depends on genetic control. Many polymorphisms related to human genes that codify cytokines are recognized and associated with phenotypes of high, medium and low production of such factors. Thus, the relation between certain genotypes and the occurrence and/or characteristics of several pathologies has been the focus of investigations. This approach may contribute with a better understanding of the pathogenesis, allowing the identification of predictive parameters and the establishment of new intervention strategies.